Log In Sign up
The largest database of trusted experimental protocols

Ceftazidime

Manufactured by Pfizer
Visit Supplier
Sourced in Germany, United States

Ceftazidime is a cephalosporin antibiotic used to treat a variety of bacterial infections. It works by inhibiting the synthesis of the bacterial cell wall, leading to the death of the bacteria.

Automatically generated - may contain errors

Lab products found in correlation

Gentamicin, by MP Biomedicals (1 mentions) Erythromycin, by MP Biomedicals (1 mentions) Rifampicin, by MP Biomedicals (1 mentions) Kanamycin, by Merck Group (1 mentions) Trimethoprim sulfamethoxazole, by Merck Group (1 mentions) Ampicillin, by Merck Group (1 mentions) Meropenem, by AstraZeneca (1 mentions) Ciprofloxacin, by Bayer (1 mentions) Ceftriaxone, by Roche (1 mentions) Meropenem, by Pfizer (1 mentions) Mh agar, by Thermo Fisher Scientific (1 mentions) Xbai restriction enzyme, by Thermo Fisher Scientific (1 mentions) Tigecycline, by Pfizer (1 mentions)

4 protocols using ceftazidime

1

Antibiotic Susceptibility Profiling of MRSA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibiotic susceptibility profiles for the VT-MRSA isolates were determined using the MIC technique via the microdilution method according to the CLSI 2013 [32 ], as described in the previous section. MIC tests were performed for ampicillin (Sigma-Aldrich), ceftazidime (Pfizer; México DF, México), ceftriaxone (Roche; Mexico DF, México), ciprofloxacin (Bayer; Levenkusen Westfalia, Germany), erythromycin (MP Biomedicals; Solon, OH, USA), kanamycin (Sigma-Aldrich), meropenem (Astra Zeneca; México DF, Mexico), rifampicin (MP Biomedicals), gentamicin (MP Biomedicals), and trimethoprim-sulfamethoxazole (Sigma-Aldrich).
Cázares-Domínguez V., Cruz-Córdova A., Ochoa S.A., Escalona G., Arellano-Galindo J., Rodríguez-Leviz A., Hernández-Castro R., López-Villegas E.O, & Xicohtencatl-Cortes J. (2015). Vancomycin Tolerant, Methicillin-Resistant Staphylococcus aureus Reveals the Effects of Vancomycin on Cell Wall Thickening. PLoS ONE, 10(3), e0118791.
+ Open protocol
+ Expand
2

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Imipenem, meropenem, ceftazidime, and tigecycline was purchased from Pfizer. MH agar was purchased from OXOID. Primers were synthesized by Sangon Biotech Shanghai Co. Ltd. Premix Taq was purchased from Takara Biotech Dalian Co. Ltd. Xba I restriction enzymes were purchased from Thermo.
Shi Z., Zhao H., Li G, & Jia W. (2017). Molecular Characteristics of Carbapenem-Resistant Enterobacter cloacae in Ningxia Province, China. Frontiers in Microbiology, 8, 94.
+ Open protocol
+ Expand
3

Preparation and Administration of Delafloxacin and Ceftazidime

Check if the same lab product or an alternative is used in the 5 most similar protocols
The intravenous formulation of delafloxacin (Melinta Therapeutics, Morristown, NJ, USA) was used in the study. Reconstituted solutions were stable for up to 24 h. Liquid suspensions were prepared fresh in 0.9% saline irrigation (SI) daily and stored at 2 to 8°C. The volume of subcutaneous (SC) administrations was 0.2 ml.
The parenteral formulation of ceftazidime (Hospira, Lake Forest, IL, USA) was used in the study and was stored under refrigeration at 2 to 8°C.
McCurdy S., Duffy E., Hickman M., Halasohoris S, & Zumbrun S.D. (2021). Efficacy of Delafloxacin against the Biothreat Pathogen Burkholderia pseudomallei. Antimicrobial Agents and Chemotherapy, 65(10), e00736-21.
+ Open protocol
+ Expand
4

Perioperative Antimicrobial Prophylaxis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ceftazidime (Tazicef, Hospira, Inc., Lake Forest, IL) was injected IV at 150 mg/kg on the day of surgery and continued through the study as long as tether once daily. Fluconazole (NorthStar Rx, Memphis, TN) was administered orally at a 50-mg flat dose per animal starting on day –5 and then once daily. Acyclovir (AuroMedics Pharma, Windsor, NJ) was delivered IV at 10 mg/kg starting on day –5, and then once daily.
Wang H., Germond A., Li C., Gil S., Kim J., Kiem H.P, & Lieber A. (2022). In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4. Blood Advances, 6(15), 4360-4372.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!